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From the Editor
Losing My Dad.....................................................1

Losing My Dad
I always knew that one day the phone call would
come. I just could not imagine processing the news
and hanging up the phone. Like most physicians,
I have delivered news of the death of a loved one
and have been at the bedside when families were
holding vigil. Many years ago, as a house officer,
I participated in the prolonged care of persons
whose case was hopeless from the start. None
of this prepared me for the call about my dad’s
death this past winter.
My dad’s passing, and my thoughts about his death,
have given new meaning and motivation to my new
role as Dean. I am more motivated today than ever
to ensure that health care professionals are trained
to work together to provide the most appropriate
care and support to their patients.
There is a robust literature by physicians writing
about the death of their parents and it seems to be
especially focused on the death of the father.1,2,3
I had been collecting some of these essays and even
shared them with my dad over the years, hoping he
would understand the role of a physician son and
the difficult decisions that families face as elderly
loved ones become frail, cognitively impaired, and
severely ill.
My father was the middle son of three brothers,
born just before the Great Depression to immigrant,
non-English speaking parents on the Lower East
Side of Manhattan. He went to kindergarten
speaking only Yiddish and had to quickly learn the
language. My grandmother, a widow most of her

life, did not read or write English. Although he
was raised in a single parent household on welfare,
as an adult he was relentlessly upbeat.
Other aspects of my dad’s childhood may sound
familiar to children of first-generation Americans:
the rapid road toward assimilation, with education
as the escape valve from the ghetto. My father was a
well educated man. He graduated from the Cooper
Union in New York City and eventually attended the
first class of the Sloan School of Management at the
Massachusetts Institute of Technology. He became
an entrepreneur, creating a successful business from
scratch that eventually went public. His business
acumen was all “relationship based,” flowing from
his uncanny ability to make friends.
My father never lost his temper and always
encouraged my brother and me in our various
pursuits, especially those related to school.
He instilled in us a sense of pride in our
accomplishments, patriotism for our country, and
a belief that the future held limitless possibilities.
His most cherished role was that of grandparent.
Nothing brought him more pleasure than extended
family vacations and other life events like bat
mitzvahs, weddings, and the like. He truly reveled
in the company of his five grandchildren and,
despite protestations from my mother, tried hard
to spoil all of them mercilessly.
Before his death, I encouraged Dad to undertake a
project to write his memoirs and contracted with
Mary O’Brien Tyrell, a writer in Minneapolis, to
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help him with the task. Ms. Tyrell visited with him,
listened carefully to the story of his life, and helped
him to document it for posterity.

opportunity to visit with all of his grandchildren.
The very next day, I got the dreaded phone call that
he had died in bed at home.

I had some trepidation in creating this contractual
relationship between my dad and Ms. Tyrell. Stories
abound whereby elderly men, in particular, focus
so much on their war-time service and business
escapades and conveniently nearly forget about
their wives and children! The project took nearly
two years of work, but I was grateful that my father
eventually saw it through. Ironically, the package
containing the forty hardcover copies of his
memoirs arrived on the evening of the day he died.
It became a prized – and instant – family heirloom.

As a son and physician, I am grateful for some of
the blessings of the brief time period between his
illness and his death.

How does all of this relate to my motivation for our
new school? Here’s the medical side of the story.
Two weeks prior to his death, my dad suffered a
small cerebral hemorrhage and was hospitalized
in a local community hospital near his home in
southeast Florida. I had an opportunity to visit
him in the hospital, where he recovered quickly.
Although he suffered no long-term motor problems,
he clearly was left with some cognitive deficits.
During his stay in the hospital, my physician
brother and I attempted to communicate with
the multiple consultants who were caring for our
father. As the number of consultants increased, the
communication became more fractionated. Our
non-system is so fragmented and poorly designed
that I can only imagine the frustration encountered
by family members without a clinical background
during the hospitalization of a loved one. My
dad suffered a hospital-acquired infection that
derailed his overall care plan until he was finally
discharged after a nearly two-week stay in the
hospital. His discharge coincided with our family
December holiday vacation to Florida, so he had the

First and foremost, my dad had an opportunity to
see all of his grandchildren while he was still able
to carry on a conversation and to sit at the table
for a family meal. He avoided a re-hospitalization,
whereby my brother and I would have undoubtedly
had to make difficult decisions regarding ceasing
intubation, life support and related medical
intervention, something he never would have
wanted to endure.
The arrival of his memoirs, within hours of his
death, was just like my dad – waiting till the last
minute to complete a project. Regrettably, he never
got to actually hold the book in his hands.
I am also grateful that we avoided what many
families increasingly face – that is, according
to Winakur2, the American narrative “of aging,
disability and dementia that is played out in your
family, in your home, when the numbers, the data,
the statistics become your loved ones, your spouse,
your parents and then yourself, you will finally
understand how wrong-headed so much of current
public healthcare policy is today.”
Delivering the eulogy at his funeral, I noted that my
brother and I and our wives – all physicians – were
grateful that my father did not endure a prolonged
hospitalization with all sorts of unnecessary testing,
consultation, and the like. I could see many of
the white-haired heads all nodding in vigorous
agreement as I expounded upon our gratitude that

a final bedside vigil never became necessary. My
heart ached for all of the families whom I know
have had to endure just such a vigil, and I felt a
wave of relief knowing what could have been.
So there you have it. I’m grateful, saddened, and
feel a big hole in my heart. Paradoxically, I am
also energized, motivated and excited about my
work and our new school. More than ever before,
I am committed to helping to fix this mess so
that other families will get a sense of patientcenteredness, better coordination of care, and
better communication from their doctors and other
caregivers. As Bobrow3 has noted, “parents must
die before their children and so my father passed
in accordance with his wishes without ever having
used a cane or a walker or ever having to rely on
anyone other than close friends or family.”
While my dad’s death was unexpected, his passing
was quick enough to burden no one. After sixty
years of marriage my mom is lonely, but she is
grateful for his lack of suffering. The enduring
lessons of my dad’s life remain as an important
guidepost for me. His advice was always sought as
the highest level of family counsel. His intellect and
his understanding of relationships allowed him to
grasp the key facts and mollify stakeholders in any
situation. Clearly, I will need to call upon these skills
too, as we move forward with some of the possible
solutions to fix our broken system. 
David B. Nash, MD, MBA
Dean, Jefferson School of Population Health

As always, I am very interested in your views. You
can reach me by email at david.nash@jefferson.edu.
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Stimulus Money and Health Care Research and Investment
On February 17, 2009 the American Recovery
and Reinvestment Act (ARRA) – or, as commonly
referred to in the media, the Stimulus Bill – was
signed into law. The legislation allocates $787
billion for federal stimulus spending in an attempt
to curb the current economic recession. Of the
total, $150 billion has been allocated to health
care (Figure 1). Health care represents the largest
proportion of dedicated funds as well as the
largest sector of the economy.1 Thus, recovery and
well-being of the economy is inexorably tied to
the condition of the healthcare industry. The $150
billion allotment is viewed as the jumping-off
point for the Obama administration’s healthcare
agenda, which seeks to increase access to services
while controlling cost. Because this will have both
immediate and long-term effects for everyone in
the nation, it is imperative for all to understand
the broad health policy implications.
Over half (58%) of the health care stimulus
funds – $87 billion– will be devoted to states
in the form of matching federal assistance for
Medicaid.2 The remainder of the health care
stimulus dollars are pegged for three broad
initiatives: comparative effectiveness research,
health information technology, and increased
funding ($10.4 billion) for the National Institutes
of Health (NIH).2,3 These three initiatives have the
potential to profoundly affect healthcare policy
and the future direction of the healthcare industry.
Specifically, the ARRA apportions $1.1 billion
for comparative effectiveness research, one of
the more controversial funding initiatives.2
Because comparative effectiveness is in its
nascent stage in the United States, many have
presupposed its implications and have a deeprooted misunderstanding of this form of science.
In its simplest form, comparative effectiveness
research can be boiled down to the comparison of
alternative treatments for a medical condition to
determine the best overall treatment strategy. 4
In practice, it is not this simple; there are many
methodological and policy challenges. Foremost,

Figure 1: Allocation of Health Care
Stimulus Funds ($150 Billion)

Comparative Effectiveness Research
Health Information Technology
Other
Medicaid and Other State Health Programs
National Institutes of Health

the Federal Coordinating Council for Comparative
Effectiveness Research (FCC-CER) was established
on March 19, 2009. Comprised of a 15-member
expert panel, the FCC-CER role is to submit reports
to Congress on the comparative effectiveness
research being conducted; it will not be able to
mandate coverage or set healthcare policy.1,4
The health care appropriation will also direct
$19.2 billion to healthcare technology and
infrastructure investments with the ultimate
goal of the implementation of an electronic
health record for every person in the United
States by 2014.2 To achieve this goal, the funds
will initially be used to provide incentives
to doctors and hospitals to adopt the use of
electronic health records.1
The money will also be used to train workers in
the use of health information technology and
improve the security of electronic health records.

researchers must determine the appropriate
outcome measure for which to compare distinct
or contrasting interventions. Another important
component of comparative effectiveness research
is economic evaluations of interventions. However,
interventions which improve health outcomes
do not always save money and, in fact, can be
significantly more expensive than the current
standard of care. As such, policy makers are forced
to determine at what costs they are willing to fund
interventions which improve healthcare.

Finally, the legislation allocates an additional
$10.4 billion to NIH (approximately 1/3 of the
current NIH budget), which must be spent in
two years.2,3 Of the total, $2.2 billion is dedicated to
capital improvements of facilities, infrastructure
and equipment to improve healthcare
infrastructure and provide jobs as a way to
stimulate the economy. The remaining $8.2 billion
is intended for peer-reviewed research grants.2

While there are clear methodological and
political challenges to conducting comparative
effectiveness research, it should not be discounted
nor touted as the savior of health reform. Rather,
when implemented as part of an overall evidencebased medicine agenda, comparative effectiveness
research has the potential to curb rampant health
care inflation and improve overall quality of care.

This tidal wave of money devoted to health care
marks the beginning of a new era in health
policy, where costs are controlled and quality is
demanded. Innovation is imperative, and novel
ideas and approaches to solving the health care
crisis are welcomed from all disciplines. In order
to sustain lasting improvement, policy makers
must remember to continue to invest in the
nation’s healthcare system after the stimulus
funds expire. 

To oversee funding of comparative effectiveness
research and to help alleviate the fear of the
government using findings from this type of
research to directly dictate medical coverage,

Eric Jutkowitz
Post-Baccalaureate Fellow
Jefferson School of Population Health
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2009 Annual Quality/Risk Management Retreat:
An Approach to Patient Safety
Peter J. Pronovost, MD, PhD, FCCM

Professor, Johns Hopkins University School of Medicine
Medical Director, Center for Innovation in Quality Patient Care
April 22, 2009
The Jefferson Health System (JHS) Quality Council
and Mountain Laurel RRG Risk Management
Committee hosted, An Approach to Patient Safety,
a Quality/Risk Management Educational Retreat
on April 22, 2009. The featured speaker for the
event was Peter Pronovost, MD, PhD, FCCM, the
Director of the Johns Hopkins University Center
for Innovation in Quality Patient Care and author
of more than 200 articles and chapters in the
fields of patient safety, quality health care, and
evidence-based medicine.
Dr. Pronovost’s presentation was organized into
two sections. The first half of the program was
dedicated to the issues and problems in appropriately measuring patient safety. It is critical to
understand how and what to measure in order to
provide a clear and accurate picture of what is
going on. He spoke about learning from mistakes,
and described teamwork tools, including daily
goals, morning briefings, shadowing, active
listening, and culture check-ups. He also discussed
difficulties in translating evidence into practice.
In the second half of the program Dr. Pronovost
spoke about strategies that can be used to improve
patient safety. He explored attitudes, culture, and
methods that are required to make substantial
progress in improving patient safety within

healthcare organizations. He stressed the use of a
conceptual model based on structure, process and
outcome to provide a context and culture of safety.
In particular, he spoke about how he approaches
the “Science of Safety” by including both
measurement issues and strategies to get
interdisciplinary groups to work together to
improve system performance.
Dr. Pronovost described some of the projects in
which he is involved, including several that focus
on improving care in Intensive Care Units (ICUs).
For example, he described a patient safety scorecard that he and his colleagues have developed
and used as a framework for safety improvement
in the ICU (refer to Table 1). 1

It was especially interesting to see how Pronovost’s
approach takes into account both the technical
(evidence-based) aspects of patient safety, as well
as the behavioral/cultural aspects of instituting
change within work groups that are part of a
larger organization. By using such an approach,
one can examine changes from several perspectives,
including the changes in structure, process, and
outcomes that result from an effort to change safety
within an ICU. 
For resources, training modules, and toolkits
related to this topic, visit: www.safercare.net.

Table 1: Patient Safety Scorecard
Domain		
How often did we harm patients?		
How often do we use evidence-based medicine?
		
How do we know we learned from our mistakes?
		
How well have we created a culture of safety?
		

Definition
Measures of health care-acquired infections
Percentage of patients who receive evidencebased interventions
Percentage of months per year the ICU learns
from mistakes
Annual assessment of safety culture at the
unit level
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Jefferson Students’ Improving Knowledge of Issues in Health Policy
Annual expenditures on health care in the US
exceed $2 trillion.1 The organization and financing
of the healthcare system have a major impact on the
practice of medicine, patients’ expectations,
and outcomes. How well do Jefferson Medical
College (JMC) students understand the US
healthcare system at the beginning of their
4
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medical education? Has this changed over time?
How does this compare to students in the Master
of Public Health (MPH) program?
A recent national survey of medical students
identified gaps in their knowledge of important
issues facing the US healthcare system.2 Using the

audience response system, 13 selected multiplechoice items from the national survey were
administered to first-year JMC students on the
first day of a series of lectures introducing the
organization and financing of the US healthcare
system and to MPH students enrolled in PH 508:
Health Policy – An International Perspective.

Table 1 offers a sample of the exam items, while
Table 2 provides a summary of the results.
While this type of casual sample is certainly
not conclusive, it appears that there is a trend of
improving scores. JMC students performed better
than their national peers in 2005, 2006, and 2007.
JMC students in the fall of 2008 and Jefferson
MPH students who responded to the same items
in January 2009 scored substantially better than
their peers from the earlier years.
How well did the students perform on specific
items? In 2005-2007, almost 40% of JMC first
year students incorrectly believed that the United
States has a lower infant mortality rate than any
other nation in the world. In the fall 2008 and
January 2009 exam, 80% of both JMC and MPH
students responded correctly. On the item asking
about health care spending, by 2008, over 90%
of students knew that the US spends more per
capita on health care than any other country in
the world.
When asked to estimate the approximate number
of people in the US without health insurance, twothirds of the MPH students knew that the correct
response is between 40 and 50 million; less than
50% of the most recent class of JMC students
responded correctly. In earlier years JMC students
had even more significantly underestimating the
number of people without health insurance. In all
years, almost all of our students did demonstrate
an understanding of some of the consequences
of lack of health insurance such as not having
a regular source of care, having avoidable
hospitalizations for diseases such as asthma and
diabetes mellitus, and delayed diagnosis of cancer.
Why have the scores improved over time? Perhaps
all the attention paid to healthcare in the fall 2008
presidential campaign heightened our students’
knowledge of some of the important issues facing
the US healthcare system. Hopefully, proposed
reforms to the US healthcare system will make the
current exam items obsolete. 
Daniel Z. Louis, MS
Research Associate Professor, Family and
Community Medicine
Managing Director, Center for Research in
Medical Education and Health Care
Jefferson Medical College

Table 1: Student Knowledge Exam Items
True or False
1. T
 he United States has a higher life
expectancy than any other nation in
the world.

9. M
 ost individuals without health
insurance are in families where no
one works.

2. T
 he United States has a lower infant
mortality rate than any other nation in
the world.

10. R
 aising the cost of co-payments or
deductibles does not affect whether
patients will go see their doctor.

3. G
 overnment-administered health
insurance (e.g., Medicare) requires more
money per person for administrative
costs than private health insurance.

11. The number of uninsured individuals
in the United States increased over
the last decade.

4. T
 he United States is the only
industrialized nation in the world not
to guarantee access to health care for
all of its citizens.
5. T
 he United States spends more per
person on health care annually than any
other nation in the world.
6. P eople without health insurance are
less likely to have a regular source of
medical care.

12. Where, approximately, did the United
States rank, out of 191 countries, in a
2000 World Health Organization
(WHO) report on “health systems
performance?”
a. Near first place
b. Near 10th place
c. Near 20th place
d. Near 30th Place
e. Near 40th place
13. How many uninsured people are there
in the United States today?
a. Fewer than 10 million
b. 10 to 20 million
c. 20 to 30 million
d. 30 to 40 million
e. 40 to 50 million
f. Over 50 million

7. P eople without health insurance are
more likely to suffer from avoidable
hospitalizations for diseases such as
asthma and diabetes mellitus.
8. P eople without health insurance are more
likely to suffer from delayed diagnoses
for diseases like cancer.

How did you score? Test your knowledge. See page 11 for the answers.

Table 2: % Correct Responses on Selected Items Concerning the US Healthcare System
Results from
national survey
published in
Academic Medicine
68%

Jefferson Medical College – 1st year students

Fall 2005		
72%

Fall 2006

Fall 2007

Fall 2008

Jefferson
MPH students
Jan 2009

72%

73%

79%

80%

Note: There were 21 student respondents from the MPH class. The JMC entering class size is 255.
Not all students were in attendance and not all responded to every item.
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The University Clinical Skills and Simulation Center: A Jefferson Gem
Part II: Interview with Dale Berg, MD and Katherine Berg, MD
Co-Directors of the University Clinical Skills and Simulation Center (UCSSC)
Now that the Clinical Skills Center has been in
the Hamilton Building for well over a year, what
type of an impact do you feel that this facility
has had on the students and their experiences?
KB:	The students are very excited; and it’s also
been nice for GME. It allows us to expand
our pre-existing curriculum and evaluation
tools, to develop in new areas and serve the
needs of many others. The building provides
a venue for educators of all disciplines and
professions to get together and teach and
develop. Members of different departments
are crossing paths and working together in
an exciting learning environment.
DB:	One of the fundamental advantages of a
simulation center is that it provides a
great venue for getting faculty to markedly
increase the time spent directly teaching
students the skills they used to teach at
the bedside.
KB: 	The Skills Center team works closely with
faculty and provides educational consultation as ideas and programs are developed.
For example, we work with the clerkship or
program director to assess and discuss their
needs; develop a set of teaching objectives;
and create a plan for product development
needed to teach the program. Most of the
time, the faculty will run their individual
program and we support and provide the
mechanism to produce it.
DB:	This building is a catalyst for creating a
collegial, team approach to curriculum
development and implementation. It
allows for cross-pollination from various
fields and professions. It is a place to learn
that is safe for the learner, and for the
simulated patient whether it be a mechanical
simulator, a human (standardized patient)
simulation or a hybrid of the two. Teaching
core skills across professions creates a rich,
dynamic learning environment. That’s why
we are so excited that Jefferson Center for
InterProfessional Education (JCIPE) is
the cornerstone of this movement, led
by Christine Arenson, MD and Molly A.
Rose, PhD, CRNP.
6
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As faculty, you have the opportunity to observe
students going through this unique educational process. What is that like?
KB: 	We teach all 4 years so we do get to see
how students develop over time. First year
students come in wide-eyed and nervous;
by 4th year they are more relaxed. The
amount of knowledge they acquire in those
four years is breathtaking. They go from
being a student to becoming a colleague,
and get to a point where they are actually
teaching one other. This is particularly true
with Jefferson’s unique Advanced Physical
Diagnosis (APD) course, an elective that
is immensely popular in the 4th year.
Approximately 75 students devote one
month to immersion in the clinical skills
set of physical examination. The course
consists of not only learning the skills,
but interpreting them, applying them to
clinical situations and then, translating the
simulation and skills directly to bedside
learning and teaching through faculty rounds
with real patients.
DB: 	The APD course helps learners refine their
skills so they can make clinical decisions in
the absence of imaging or lab support. In
those situations, a Jefferson-trained clinician will be able to call upon the skills set
that requires only a history and physical at
minimum to provide care to their patients
and develop a reasonable diagnostic and
therapeutic paradigm. Our view is that
because a primary care provider encounters
undifferentiated problems, he or she must
master history and physical examination
with great acumen.
Describe the feedback, assessment, and
evaluation process. How is it standardized?
Is there a variation depending on the program?
KB: 	We do both formative and summative
assessment, at every level. Most of our
summative assessment is done via
standardized patients and checklists.
At the end of the year all 3rd year students
take an Objective Structured Clinical Exam
(OSCE), which includes 11 stations of
standardized patients. The exam consists

of different scenarios where students must
exhibit their communication skills, physical
exam skills, counseling skills, and data
recording/documentation skills. Students
who don’t pass must spend a month in a
remedial course (directed by Dr. Joseph
Majdan) to get their clinical skills up to our
standards. The OSCE also provides a venue
for the students to prepare themselves for
the Competitive Exams (CX).
	At the end of the 3rd year clerkship, in
addition to the Standardized Patient (SP)
assessment, we also conduct a hybrid of
the SP and the mechanical simulation. The
scenarios include an acute process that
requires the student to put in an IV or NG
tube, for example. Rather than doing the
procedure on the SP, the student performs the
procedure on the model. For instance, in OB/
GYN, for an SP who is “in labor,” the student
would have to deliver a baby on Noelle™
(a simulation mannequin that delivers
babies). The student would also have to communicate with the SP during the procedure.
It’s very difficult to both have the skills, the
hand-eye coordination, and also communicate to a patient what you need them to do.
DB: 	Jefferson is really in the forefront with this
innovative hybrid – or, as we like to call it, a
chimera – model of simulation that combines
plastic with a human example. For example,
the cardiopulmonary patient simulator,
Harvey® gives you in vitro sounds of a
murmur along with a real patient who
exhibits that same murmur.
KB: 	Although it has been shown that SPs are
fairly good at assessing history taking,
communication skills, and the physical
exam, we are also studying the effectiveness
of having the SP grade the students on their
technique of a procedure.
Would the SPs need more training in order to
achieve that?
KB: 	Yes. We record all the sessions. We also have
another standardized patient simultaneously
evaluating the SP’s performance. In other
words, there is somebody behind the mirror

or behind the curtain, and we have somebody
who is watching the scenario on tape in real
time. They both complete the same checklist.
We compare responses to determine how
closely they coordinate. Observation in real
time is preferred over the SP who is with the
student and completes the checklist after
the student leaves the room.
DB: 	Using checklists, faculty leaders supervise
and set exacting standards for training these
SPs. There are specific steps and nuances in
physical examination and history taking that
we expect our second year students to be able
to perform. After their training at the Center,
the SPs know these steps and become an
extraordinary resource for teaching. We like
to think of them as teacher extenders in that
they assist the faculty in teaching the skills
set in a humanistic yet controlled way.
Are the scenarios used constantly evolving?
DB: 	The Center allows us to effectively
democratize the process of developing
simulation support and curriculum for
various programs across the University and
in the region. Faculty with ideas for projects,
programs, and research come in from any
department, source or site on campus
and we work with them to implement a
program based on their ideas. We will sit
down together to create a template, come
up with ideas and then write a screenplay;
or, if they want to write a script, we help to
edit it so that we can produce it. With the
assistance and expertise of Rob Hargraves,
managing producer of Jeff Players, and a
cinematographer from the Jefferson Medical
Media Department, we write a screenplay,

cast actors, set up a credible stage, rehearse,
and then produce and edit. A prime example
is the series on teaching conflict resolution in
the ER, which we developed in collaboration
with Alan Forstater, MD, of Emergency
Medicine. Of the 11 different scenarios
shared by Dr. Forstater, we have 5 available as
professional quality video clips for teaching
and role modeling purposes. Using our Jeff
Players acting and production group, we have
created a library of over 45 competencybased professional quality teaching video
trigger clips.
How do we know if the use of simulation and
SPs make a difference in outcome?
KB: 	That is the big question nationwide and
many studies are being proposed. Most of the
research done has been qualitative: “yes,
I feel better; yes, I feel more prepared; yes, I
think this is a good curriculum.” While the
jury is still out, I think that it does make a
difference, especially in terms of confidence.
DB: 	The policy of the University Simulation
and Clinical Skills Center (UCSSC) is that
educational research should be conducted on
new programs with an eye toward publishing the results. This will thus increase the
credibility of our teaching and of our Center.
We are currently working with Ed Jasper, MD,
Clinical Assistant Professor and Director of
Emergency Medical Services, to develop a
scientific assembly for the fall of this year.
KB: 	We try to perform qualitative and quantitative research. We have had many abstracts
and presentations accepted to national,
international and regional meetings over the

past year. More research projects are planned
for the future.
DB: 	We are lucky to have resources like the Center
for Research in Medical Education (CRIME)
and, in particular, J. Jon Veloski, MS, who is
the Director of Medical Education Research
at the Center and a distinguished researcher
in this field. Together, we work with faculty
at our UCSSC research meeting to develop
research protocols, and foster collaborative
writing and scientific thinking of methods
for teaching and uses of specific clinical
skills sets.
What else would you like our readers to know?
KB: 	I would modify the old model of see one,
do one, teach one – it’s see one, practice one
and simulation, do one, teach one. We are
not trying to supplant the whole idea of
patient-centered medical education, we are
just trying to add that little practice step.
DB: 	This is the 21st century iteration of providing
training and practice to a new generation
of health care providers. Simulation allows
a teacher to develop metaphors in innovative ways and provides the opportunity to
collaborate with others on campus with a
zest for teaching and learning. This is a place
where educational research is going to take
off. Jefferson is in the forefront of this new
paradigm for teaching. 
Interview Part I appeared in the March 2009 issue
and is available at: http://jdc.jefferson.edu/hpn.
Interviews conducted and edited by
Emily Frelick, MS
Project Director, Continuing Professional Education
Jefferson School of Poulation Health

The Mayo Clinic Health Policy Center
National Symposium on Medical and Health Education Reform
April 26, 2009
The Mayo Clinic convened a National Symposium
on Medical and Health Education Reform in
Rochester, Minnesota. Health care professionals
and educators from a variety of disciplines were
in attendance, with the goal of developing a list of
recommendations to support the reform agenda.
Dr. Denis Cortese, president and CEO of the Mayo
Clinic, opened the symposium by presenting

the 4 cornerstones of health reform: 1) create
value, 2) coordinate care, 3) reform the payment
system, and 4) provide health insurance for all.
Meaningful education for health professionals
is an important factor in achieving these goals
and in improving the overall quality and safety
of health care. This includes interdisciplinary
education focused on teamwork and
care coordination.

Key takeaway messages from the symposium
include the need for: a shared vision; development
of competencies that lead to progress toward
goals; assessments that adequately measure
performance; educational opportunities
in training and in practice to support and
reinforce an integrated delivery system; and
a common language and communication
tools across disciplines. 
FEBRUARY 2009
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Master of Science in Healthcare Quality and Safety (MS-HQS)
One of our new degree programs is a Master of
Science in Healthcare Quality and Safety. Students
who complete this degree will be able to apply
advanced management and leadership skills
to develop approaches that address problems
related to the measurement and improvement of
healthcare quality and patient safety.

We are eagerly preparing for our first cohort of
students, who will begin classes in September.
Classes will be offered across three 14-week
sessions each year, with breaks between each
session. Our classes will be held in the evenings,
since we expect that many of our students will be
working full-time and attending school part-time.

Graduates will be able to apply the quantitative
and qualitative analytic skills they acquire in a
variety of settings, including inpatient facilities,
outpatient and office care, nursing home and
home health programs, psychiatric and drug
treatment programs, and agencies providing endof-life care. Our students will also find work with
health insurance organizations, governmental
agencies at the state and federal level, research and
consulting firms, and advocacy organizations.

We have hosted three open house events for
prospective students to learn more about our
program, and also sponsored advertisements
on public radio, in newspapers, and on
transportation systems in Southeastern
Pennsylvania. Also, our brochures were widely
distributed at local events and lectures related
to health care quality and safety.
Applications are being taken online for the fall
2009 and spring 2010 semesters. The admissions

process includes a personal statement, official
transcripts from colleges and universities
attended, GRE scores, and two letters of
recommendation. There is a $25 fee, and standard
application forms to complete. There is no
deadline; applications are being reviewed on a
rolling basis in batches in order to provide rapid
turnaround. Eligible candidates will be called
in for a personal interview. 
Susan DesHarnais, PhD, MPH
Program Director
Health Care Quality and Safety
Jefferson School of Population Health

Complete information on the program and the
application process is available online at http://
www.jefferson.edu/population_health/quality_
safety/, or you may call (215) 503-5305.

The Impact of Education on Health Care Quality
The 18th Annual Dr. Raymond C. Grandon Lecture
Thomas J. Nasca, MD, MACP
May 7, 2009
To kick off his keynote presentation at the 18th
Annual Dr. Raymond C. Grandon Lecture, Thomas
J. Nasca, MD, MACP, the former Dean of Jefferson
Medical College, had an important reminder for
the physicians in the audience: the work they
do produces a social good. That social good, Dr.
Nasca continued, is the equitable distribution of
the “good” of health care and the restoration of
health – wherever possible to members of society.
Dr. Nasca’s lecture, “The Impact of Education on
Healthcare Quality,” touched on the challenges
facing medical education in the United States and
the importance of understanding the fundamental
roots of the medical profession.
Dr. Nasca is currently the Chief Executive Officer
of the Accreditation Council for Graduate Medical
Education (ACGME), a private, non-profit council
that evaluates and accredits medical residency
programs throughout the United States. A
board-certified internist and nephrologist, Dr.
Nasca received his undergraduate degree from
the University of Notre Dame in 1971, and his
8
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medical degree from Jefferson Medical College in
1975. In 1992, he joined Jefferson Medical College
and Thomas Jefferson University Hospital as Vice
Chairman of the Department of Medicine, where
he directed the undergraduate and graduate
medical education programs of the department.
Having established that healthcare is one of
the goods of society, Dr. Nasca posited that
social justice is what compels physicians to
administer its distribution. Taking it one step
further, Dr. Nasca cited the Hippocratic Oath.
“It comes down to nine words,” Dr. Nasca said,
“these things I do solemnly swear, upon my
honor – the last nine words of the Hippocratic
Oath compels us to do this.”
In order to improve quality and safety outcomes,
Dr. Nasca suggested physicians look to Tiger
Woods as a role model. Woods, the number one
golfer in the world, is known for grueling practice
sessions where he’ll hit the same difficult shot – a
buried lie behind a tree, for example – 100 times
before moving on to another, which he will also

hit 100 times. Physicians, Dr. Nasca said, don’t
practice challenging situations intentionally; they
practice circumstantially. Medical students are
encouraged to study, Dr. Nasca noted, but there
is more to medicine than knowledge.
While healthcare professionals must always
strive for improvement, Dr. Nasca concluded,
it is important to remember that the quality
of healthcare provided in academic medical
centers is “statistically, significantly better in
every metanalysis” than what is provided in
non-teaching hospitals. “We should be proud
of what we do because we do it well,” Dr. Nasca
said. “That’s what we’re committed to. We’re
committed to continuing excellence.” 
To listen to an audio recording of this lecture visit:
http://jdc.jefferson.edu/hplectures/6/.

Change Your Life.
Change Health Care.
• Master of Public Health (MPH)
• Master of Science in Health Policy (MS-HP)
• Master of Science in Healthcare Quality
and Safety (MS-HQS)

Exemplary academic programs preparing
global leaders to improve population
health and enhance the quality of life.

Philadelphia, PA

215-503-5305

www.Jefferson.edu/population_health/

THoMaS JefferSon UniverSiTy

The Patient Navigator Outreach and Chronic Disease Prevention
Act of 2005: A bipartisan approach to improving access to care
and addressing health disparities
Too frequently, patients with the greatest health
care needs have the least ability to comprehend,
access, and navigate the U.S. health care system.
A variety of factors, including: low educational
levels (and resultant issues regarding literacy in
general and health literacy in particular); limited
English proficiency (LEP); poverty; and a lack
of knowledge on the part of the practitioner
towards patients’ cultural beliefs and practices,
can exacerbate this chasm between the healthcare
consumer and the provider. It can be difficult
and time-consuming for providers to help some
patients to understand how best to participate
in their own care. Patient navigators were
created to provide appropriate support to this
patient population in an effort to improve their
health outcomes.
Patient navigators may be community health
workers, lay health educators, peer health
promoters, medical assistants or nurses who
serve as liaison between patients and providers
to promote health among groups that may lack
access to adequate health care. The purpose of
a Patient Navigator is to help reduce health care
disparities; facilitate communication between
patients and providers; assist patients in
overcoming barriers to care; shape perceptions
individuals may have about disease and specific
health-related behaviors; provide outreach
services and educational support; and offer
culturally and linguistically competent assistance.
In 1989 Dr. Harold Freeman, a surgical oncologist
at Harlem Hospital, became concerned over
the large numbers of women from the local
community presenting with late-stage breast
cancer, despite the availability of routine screening
for the disease. As the National President of the
American Cancer Society, he conducted a series of
hearings throughout the US to get feedback from
community members about the impact of cancer
on their lives. After hearing common accounts of
References

significant barriers to care, he determined that the
obstacles for cancer prevention, early detection,
treatment and support were surmountable.
In 1990, Dr. Freeman created the first “patient
navigation” program at Harlem Hospital Center
in New York City, funded by a grant from the
American Cancer Society1.
In 2005, policymakers came together to support
the Patient Navigator Outreach and Chronic
Disease Prevention Act of 2005 (Public Law
109-18). With unanimous support in Congress,
and under the leadership of Senator Robert
Menendez (D-NJ), the Act amended the Public
Health Service Act and became Public Law,
authorizing the Secretary of Health and Human
Services to make grants through 2010 for the
development of patient navigator programs.
A total of $25 million was awarded over five
years for patient navigator programs through the
Community Health Centers at Health Resources
and Services Administration (HRSA), the Office
of Rural Health Policy, the National Cancer
Institute (NCI), and the Indian Health Service.2
The overall purpose of the funding is to
determine if patient navigators help reduce
barriers to access to care and improve health care
outcomes in underserved patient populations.
Research has shown that patient navigator
interventions produce greater rates of screening
and follow-up on diagnosis, resulting in better
health outcomes. For example, in a study on
colorectal cancer screening within a large urban
hospital, two patient navigators were hired
for a study period. Broken appointment rates
went from 67% to 5% in one month, with the
likelihood of keeping the appointment for the
colonoscopy increasing by nearly three times3.
Another colorectal cancer screening study within
a minority community health setting compared
two groups of patients with similar demographic
characteristics who were recommended

colonoscopy services by their physicians. The
patients from the navigator-assisted group had a
15.8% compliance rate, compared with only 5% in
the non-navigator-assisted group. The navigatorassisted group also achieved higher rates of fecal
occult blood test completion than the nonnavigator-assisted group (42.1% vs. 25%).4 Ronald
Myers, PhD, DSW, Professor in the Department of
Medical Oncology at Jefferson Medical College,
is currently leading a patient navigation project
funded by the NCI Center for Reducing Cancer
Health Disparities. Dr. Myers’ study, Increasing
Colon Cancer Screening in Primary Care Among
African Americans, seeks to determine the impact
of preference-based message tailoring navigation
on colorectal cancer screening in primary care at a
population level. Einstein is a participating site for
the study, with investigators from the Center for
Urban Health Policy and Research serving as part
of the research team.
In the studies mentioned, Patient Navigator
Programs helped reduce health care disparities
by facilitating communication between patients
and providers; assisting patients in overcoming
barriers to care; providing outreach services
and educational support; and offering culturally
and linguistically competent assistance. Patient
navigator programs that yield sustained long-term
clinical benefits and improve health outcomes and
compliance are likely to also provide economic
benefits to our health system. By funding programs
that target underserved patient populations, the
Patient Navigator Act of 2005 has the potential to
contribute to improved access and efficiency of
care and engage patients into taking a more active
and informed role in their own health care. 
Natalia M. Urrea, BA, Health Policy Intern*
Einstein Center for Urban Health Policy
and Research
Albert Einstein Healthcare Network
* This work was completed while Ms. Urrea was an intern at the Center.

1.  Backgrounder. Harold P. Freeman Patient Navigation Institute. The Harold P. Freeman Institute for Patient Navigation Web site. http://www.hpfreemanpni.org/. Accessed November 10, 2008.
2.  GovTrack.us. H.R. 1812--109th Congress (2005). Patient Navigator Outreach and Chronic Disease Prevention Act of 2005. Federal legislation database Web site. http://www.govtrack.us/
congress/bill.xpd?bill=h109-1812. Accessed Nov 10, 2008.
3.  Nash D, Azeez S, Vlahov D, Schori M. Evaluation of an intervention to increase screening colonoscopy in an urban public hospital setting. J Urban Health. 2006 March;83(2):231-43. http://
www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2527164. Accessed October 13, 2008.
4.  Jandorf L, Gutierrez Y, Lopez J, Christie J, Itzkowitz SH. Use of a patient navigator to increase colorectal cancer screening in an urban neighborhood health clinic. J Urban Health. 2005
June;82(2):216-24. http://www.springerlink.com/content/m6h4635852004x26/fulltext.pdf. Accessed October 13, 2008.
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Follow-On Biologics, Patient Safety and Policy,
Focus of JSPH Program in DC
National Press Club
April 21, 2009
On April 21st, JSPH sponsored an event at the
National Press Club in Washington, DC entitled:
“Regulation of Follow-on Biologics: Ensuring Quality
and Patient Safety.” Supported by an unrestricted
educational grant from sanofi-aventis, the event
brought together a wide range of experts in
the medical field including doctors, scientists,
economists and others who discussed the quality
and safety issues surrounding the creation of a
regulatory pathway to bring follow-on biologic drugs
to market in the United States.
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brought together a wide range of experts in
the medical field including doctors, scientists,
economists and others who discussed the quality
and safety issues surrounding the creation of a
regulatory pathway to bring follow-on biologic drugs
to market in the United States.

Featured speakers included: Michael McCaughan,
Editor in Chief of the Pink Sheet; Ann Witt, JD, Health
Counsel to Rep. Henry A. Waxman; Brian Harvey,
MD, PhD, VP, Regulatory Policy, sanofi-aventis; Terry
Hisey, Vice Chairman, U.S. Life Sciences Leader,
Deloitte LLP; and Geno Merli, MD, FACP, FHM, Chief
Medical Officer, Thomas Jefferson University Hospital
and Director, Jefferson Center for Vascular Diseases at
Jefferson Medical College.
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Research and development costs for biologics
are very high and, as a result, therapy with these
agents for patients with chronic diseases is very
expensive. Because these products are derived by
modifying living organisms, the end product is
especially sensitive to damage or contamination,
and small differences in the manufacturing
process may have unforeseen and unintended
effects on therapeutic action.

Research and development costs for biologics are
very high and, as a result, therapy with these agents
for patients with chronic diseases is very expensive.
Because these products are derived by modifying
living organisms, the end product is especially
sensitive to damage or contamination, and small
differences in the manufacturing process may have
unforeseen and unintended effects on therapeutic
action.

There is a movement to spur the development of
“follow-on” biologics (FOBs) similar to the original
products in an effort to improve access and lower
overall costs to the health care system. Congress is
intent on passing legislation enabling the Food and
Drug Administration (FDA) to develop a regulatory
pathway for FOBs similar to the pathway for generic
forms of traditional drugs. Well crafted legislation for
FOBs will afford an opportunity to reduce drug costs
and make better quality healthcare more affordable
for millions of American families.
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Currently, there are competing bills under
consideration in the House; one authored by Rep.
Henry A. Waxman (D-Calif.), Chairman of the
House Energy and Commerce Committee, and the
other drafted by Rep. Anna Eshoo (D-Calif.). In the
Senate, Charles Schumer (D-NY) has introduced a
companion to the Waxman proposal.
At the conference, there was broad support for greater
accessibility of FOBs. However, significant concerns
were expressed for patient-safety,“interchangeability”
problems and product testing issues that must be
thoroughly addressed.
Some key themes on patient safety which emerged
from the event are as follows:
1. Patient safety must be the number one priority,
including adequate safety testing prior to the
approval of any FOB.
2. The US should adopt some of the more successful
and proven provisions of European regulation,
such as its clarity around the circumstances and
extent of testing required of FOBs.
3. An FOB approval pathway must be comprehensive
and recognize the complex nature of all
biologic medications, including proteins and
polysaccharides.
4. Biologic efficacy is not the same as biologic
effectiveness. FOBs must be evaluated for patient
outcomes.
The outcome of this debate is likely to have farreaching implications with regard to access, cost, safety,
and therapeutic impact for thousands of patients with
serious, life-threatening, and chronic diseases. 
The conference webcast has been archived and can be
accessed online at:
www.visualwebcaster.com/FOB-Policy-Forum.

Student Knowledge Exam: Correct Responses
(1) False

(2) False

(12) e. Near 40th place

(3) False

(4) True

(5) True

(6) True

(7) True

(8) True

(9) False

(10) False

(11) True

(13) e. 40 to 50 million
FEBRUARY 2009

|

11

Health Policy Forums
The Public-Private Balance in Healthcare: Political and Economic Tipping Points
C. Alan Lyles, ScD, MPH

Henry A. Rosenberg Professor of Public, Private, and Nonprofit Partnerships
University of Baltimore

March 11, 2009
The United States Constitution’s separation
of authorities between our national and state
governments, coupled with an historically
significant role for the private versus the public
sector, produces a tale of too many moving
parts. Health is a state responsibility and
federal involvement is, with some exceptions, a
consequence of programs that rely on federal
funding. The complexity of this relationship was
presented by Alan Lyles, ScD, MPH, a Visiting
Professor in the Jefferson School of Population
Health and the Henry A. Rosenberg Professor of
Public, Private and Nonprofit Partnerships at the
University of Baltimore.

Dr. Lyles described the pastiche of market-based
health insurance, accrediting authorities and
care provision that precludes a unified – or
even coherent – national health policy. Instead,
maintaining a balance is more like pushing
string – it is achieved through contractual,
financing and regulatory procedures rather than
direct authority. This arrangement can lead to
innovation in health care services, but it can also
pose competing pressures on participants. The
marketplace has a short-term horizon and is
accountable to shareholders for specific financial
results. By contrast, government policies reflect
a longer horizon and are based on equity and
efficiency goals. The accidents of political and

economic history rather than planned rational
design produced the unwieldy health care system
that currently exists. Its costs, inefficiencies, even
pathologies, have led to an emphasis on evidencebased decisions. Where the politics of health care
reform seem to have a 1,000 points of ‘no,’ the
cost of not changing appears unsustainable. This
describes the perennial condition confronting
health care reformers. In summary, the collapse of
our economy, the disappearance of employmentbased insurance and the urgency of American
industry’s regaining global competitiveness are
tipping points that may propel significant change
in the tottering balance between public and
private sector roles. 

The Impact of Serious Medication Errors for Health Care Providers
Zane Robinson Wolf, PhD, RN, FAAN
Dean and Professor
School of Nursing, LaSalle University
April 8, 2009

Medication errors have the potential to cause
serious harm to patients. What is often not
considered is the profound impact these errors
can also have on the personal and professional
psyche of health care providers. Zane Robinson
Wolfe, PhD, RN, FAAN, Dean and Professor of
La Salle University’s School of Nursing, presented
her extensive research on medication errors,
including the historical and cultural context of
responses to errors.

and preventing illness. Additionally, the notion
of a perfect nurse or doctor is a model that is
reinforced through education and peer approval.

Dr. Wolfe first explained the framework and
interplay of the landscape for errors and
subsequent consequences. Health care is stressful
work performed in high-consequence systems
where there is a significant potential for error. The
level of personal and professional responsibility
for patient care, and the expectations surrounding
these responsibilities, carries a certain weight
and burden. Health care errors are in complete
conflict with the goals of alleviating suffering

Dr. Wolfe also described research related to
the disclosure of errors. Patients not only want
to be told about errors during their care, they
want to know why and how the error occurred,
and what will be done in the future to prevent
similar errors. Patients and family members want
a sincere, prompt, and compassionate apology.
There is sometimes a disparity between patients
and relatives and their desire for open, honest
communication and what physicians actually do.
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Traditionally, there has been a culture of
blame and silence related to error. Some of the
consequences of this culture are underreporting
of error events and clinician self-blame. This
culture has also served to hinder meaningful
improvements in practices and systems.

Physician reluctance to fully disclose is often based
on their own emotions, discomfort, and fears.
The emotional impact of an error on a provider is
not something that is typically openly discussed.
Dr. Wolfe explored the psychological dynamics
that often take place, even long after an error has
been made. There is often a barrage of emotions
from doubt, self-blame, sleep loss, lack of job
confidence, anxiety, embarrassment, guilt, and
remorse. On a more practical level, providers
may face real consequences, such as probation,
suspension, termination, or criminal prosecution.
Dr. Wolfe discussed the process that takes place
when an error has occurred and she emphasized
the need for support, education, resources, and
counseling. Ideally, organizational approaches
such as Employee Assistance Programs (EAP)
and team interventions help to diminish the
long-term emotional impact and affect change. 

Upcoming Health Policy Forums
Innovative Approaches to Medical Education
September 9, 2009

Building Patient Centered Medical Homes
in America’s Poorest City – Camden, NJ
November 11, 2009

M. Brownell Anderson, M, Ed
Senior Director, Education Affairs
Association of American Medical Colleges

Jeffrey Brenner, MD
Medical Director
Camden Coalition of Healthcare Providers

Philadelphia’s Public Health Priorities
and Initiatives: Implications for
Improving the Health of Vulnerable
Populations

Achieving Cultural Competency:
Using a Case-Based Approach for
Teaching and Learning

Wednesday, October 14, 2009

December 9, 2009

Donald Schwarz, MD, MPH
Deputy Mayor, Health and Opportunity
Philadelphia Department of Public Health

Lisa Hark, PhD, RD
Project Manager, Online Medical Education
Wills Eye Institute

Please note all forums will take place at:

Horace M. DeLisser, MD
Associate Dean, Spirituality and Cultural Competency
University of Pennsylvania School of Medicine

Bluemle Life Science Building
233 South 10th Street, Room 101
Philadelphia, PA 19107
8:30 a.m. – 9:30 a.m.

For more information contact:
(215) 955-6969

Book Review
M Robinson, Novelli A, Pearson C, Norris L, eds.
Global Health and Global Aging
San Francisco, CA: Jossey-Bass; 2007.
Global demographic transformation in the
21st century will most likely be characterized
by population aging. In 2006, 11 percent of the
world’s population was 65 years or older. This
number is expected to reach 22 percent (nearly
two billion people) by 2050. Global Health and
Global Aging is a comprehensive report that
offers diverse positions and perspectives from 41
international experts, and a thought-provoking
foreword by Robert N. Butler, MD, a leading
authority on aging and President and CEO of
International Longevity Center - USA.
The book is organized into five major sections.

Part One, The World and Its Aging Population,
presents an overview of the topic, including
a global synopsis of demographic trends and
a discussion of international policies and
institutional leadership challenges affecting the
aging population.
Part Two, Countries with High Rates of Longevity,
highlights the opportunities and successes of
countries with record high rates of longevity.
Chapter 8, by Pekka Puska, the director general
of the National Public Health Institute of Finland
(KTL), describes well-planned actions in Finland
that had a positive effect on lifestyles and led to

a decrease in chronic diseases, thereby resulting
in increased health, functional capacity, and wellbeing in old age.
As is evident in Part Three, Countries Facing
Rapid Population Aging in the Next Twenty to
Thirty Years, issues of aging and global health
facing different countries can take a dramatically
different shape. While the average life expectancy
in Europe is 75, it hovers around 50 years in the
developing world largely due to poverty, malaria,
TB, AIDS, and vaccine-preventable diseases. But as
the fight against infectious diseases gains ground,
older populations will grow in the developing
Continued on page 14
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world as well, and chronic conditions will come to
the forefront.
Developing countries will be presented with
a unique set of challenges as their populations
age mainly because, as Alex Kalache, chief of
the World Health Organization’s Aging and
Life Course Program, states in Part Four,
“industrialized countries became rich before
they became old, while developing countries will
become old before they become rich.” Entitled
Leaders in Research and Innovative Programs,
Part Four highlights novel transportation,
housing, financing, and education programs
developed in government, business, and social
sectors to create healthy environments and
improve the healthcare and quality of life of the
aging population. The experiences and research
programs discussed can serve as examples for
countries seeking sustainable solutions to the
issues facing their aging population.

Part Five, Epilogue: The Road Ahead, looks
to the future and discusses country-specific
opportunities for the improvement of programs,
attitudes, and policies developed for their
aging population.
There are a few key themes that emerge
throughout the book. First, each culture offers
unique resources and insights to the new realities
of its aging population. Most importantly, global
health and aging is an international phenomenon
and demands a new international perspective and
collaboration. To promote better health, countries
around the world need to draw from the collective
experience and wisdom to strengthen their health
systems with an appropriate emphasis on the
needs of their own aging population.

opportunities facing aging populations worldwide.
Besides being a well organized volume, written by
high-profile public policy experts, it might satisfy
the reader to know that all the book’s royalties will
go directly to AARP, the non-profit advocacy and
policy organization dedicated to the needs and
interests of those 50 and older. 
Reviewed by
Safiya Abouzaid, PharmD
Pharmacoeconomics and Outcomes
Research Fellow
Jefferson School of Population Health

Global Health and Global Aging is a wonderful
resource for those seeking to better understand
the circumstances, challenges, threats, and

The Greater Philadelphia Schweitzer Fellowship Program:
Celebration of Service Ceremony
May 20, 2009

Left to right: Nicole M. Cobb, Program Director; Christine Chung, Stephanie Staples, Ashley Darcy, Noel Ramirez, Elizabeth Daly, Cameron Bass, Megan Riley, and
Program Chair, David B. Nash, MD, MBA (Dean, Jefferson School of Population Health). Not pictured: Yewah Jung, Erin Lewis, and Anita Yang.
For more information about the Greater Philadelphia Schweitzer Fellowship Program contact:
Nicole M. Cobb, MAOM, Program Director
(215) 955-9995
nicole.cobb@jefferson.edu
www.schweitzerfellowship.org
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School of Population Health Publications
Clarke, JL. The accountability conundrum:
staying focused, delivering results - a report
on the UHC 2008 quality and safety fall
forum. Am J Med Qual. 2008; 24
(Supplement):5S-18S.
Clarke JL, Skoufalos A, Nash DB and Toppy
E. The future of biologics, part I. Opportunity,
resources, and affordability: multistakeholder
perspectives. Biotechnol Healthcare. 2009;5(1): 26-34.
Gagne JJ, Maio V. Commentary: Pharmaceutical
care for migraine and headache patients:
community-based, randomized intervention.
The Annals of Pharmacotherapy. 2009;
43: 550 - 551.
Greene SE, Nash DB. Pay for performance: an
overview of the literature. Am J Med Qual, 2009;
24(2): 140-163.

Hall J, Gray S, A’Hern R, Shanley S, Watson M,
Kash KM, Croyle R, Eeles RGenetic testing
for BRCA1: effects of a randomized study of
knowledge provision on interest in testing and
long term test uptake; implications for the NICE
guidelines. Familial Cancer. 2009;(8): 5-13.
Kash KM, Leas BF, Clough, J. Dodick DW,
Capobianco DJ, Nash DB, Bance L. ACGME
competencies in Neurology: Web-based
objective simulated, computerized clinical
encounters. Neurology. 2009;(72): 893-898.
Nash DB, Jacoby R. Promises and pitfalls of the
medical home. Medpage Today. March 10, 2009.
http://www.medpagetoday.com/Columns/13193.
Accessed May 16, 2009.
Nash DB. Biologics: an important factor
in the healthcare equation. Medpage Today.

May 4, 2009. http://www.medpagetoday.com/
Columns/14034. Accessed May 16, 2009.
Nash DB. R&D redux. P&T. 2009; 34(4):4.
Nash DB. Playing games. Biotechnol Healthcare.
2009; 6 (1): 3.
Sarfaty M, Abouzaid S. The physicians
response to climate change. Family Medicine:
The Official Journal of the Society of Teachers
of Family Medicine. 2009; 41(5): 358-363.
Sifri R, Sarfaty M, Sharma S. The use of
electronic health records in optimizing the delivery
of colorectal cancer screening in primary care.
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